lactitol has been researched along with Hepatic Encephalopathy in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (25.58) | 18.7374 |
1990's | 17 (39.53) | 18.2507 |
2000's | 8 (18.60) | 29.6817 |
2010's | 6 (13.95) | 24.3611 |
2020's | 1 (2.33) | 2.80 |
Authors | Studies |
---|---|
Almaghrabi, M; Brar, S; Khan, MQ; Liang, A; Qumosani, K; Teriaky, A | 1 |
Albert, K; Galambos, I; Haktanirlar, G; Koris, A; Molnár, MA; Nath, A; Varga, Á; Vatai, G | 1 |
Sharma, BC; Sharma, P | 1 |
Morillas, RM; Planas, R; Sala, M | 1 |
Gluud, LL; Morgan, MY; Vilstrup, H | 2 |
Fujiki, R; Fukunaga, M; Kato, A; Santa, Y; Yoshimura, T | 1 |
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
Castells, L; Coll, I; Fernández-Rodríguez, C; Mas, A; Pardo, A; Planas, R; Rodés, J; Rodrigo, L; Rodríguez-Martínez, D; Sunyer, L; Vargas, V | 1 |
Als-Nielsen, B; Gluud, C; Gluud, LL | 2 |
Als-Nielsen, BE; Gluud, CN; Gluud, LL | 1 |
Angeloni, S; Attili, AF; Bezzi, M; Efrati, C; Masini, A; Merli, M; Nicolao, F; Riggio, O; Salvatori, FM | 1 |
Ghanta, RK; Mullen, KD; Putka, BS | 1 |
Blei, A; Grüngreiff, K; Jalan, R; Kircheis, G; Marchesini, G; Morgan, MY; Riggio, O; Weissenborn, K | 1 |
Bircher, J; Bührer, M; Franz, K; van Velthuijsen, JA | 1 |
Hirata, Y; Kimura, K; Ozaki, T; Sato, S; Suzuki, K; Watanabe, M; Yoshikuni, Y | 1 |
Itoh, S; Katoh, M; Kimura, K; Kotani, E; Matsumoto, A; Mushiroi, T; Ozaki, T; Ueda, F; Ukai, Y; Watanabe, M | 1 |
Hayashi, M; Ito, Y; Okawa, S; Tamai, S; Tarao, K | 1 |
Benetti, G; Maggi, A; Moser, P; Salerno, F; Vitaliani, G | 1 |
Chan, CY; Huang, YS; Jeng, WC; Lee, SD; Pai, CH | 1 |
Hirata, Y; Kimura, K; Mushiroi, T; Ozaki, T; Shibahara, R; Ukai, Y; Watanabe, M | 1 |
Hirata, Y; Kimura, K; Ozaki, T; Watanabe, M; Yoshikuni, Y | 1 |
Fehér, J; Prónai, L | 1 |
Cammà, C; Fabbri, A; Fiorello, F; Marchesini, G; Pagliaro, L; Tinè, F | 1 |
Boca, M; Duris, I; Kolibás, E; Kratochvíl'ová, E | 1 |
Caschera, M; Diofebi, M; Merli, M; Piat, C; Pinto, G; Riggio, O | 1 |
Blanc, P; Daures, JP; Gremy, F; Larrey, D; Michel, H; Peray, P; Pierrugues, R; Rouillon, JM | 1 |
Capocaccia, L; Merli, M; Riggio, O | 1 |
Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Riggio, O; Tremiterra, S; Ziparo, V | 1 |
Bird, SP; Gurr, MI; Hewitt, D; Ratcliffe, B | 1 |
Capocaccia, L; Riggio, O | 1 |
Candiani, C; Concia, E; Perversi, L; Scevola, D; Zambelli, A | 1 |
Alonso, M; Morgan, MY; Stanger, LC | 1 |
Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Pieche, U; Pinto, G; Riggio, O; Tremiterra, S; Ziparo, V | 1 |
Heredia, D; Orteu, N; Rodés, J; Terés, J | 1 |
Hawley, KE; Morgan, MY; Stambuk, D | 1 |
Garcia-Ramos, G; Gil, S; Guevara, L; Perez, F; Ravelli, GP; Toledo, H; Uribe, M; Vargas, F | 1 |
Clark, ML; Dawson, AM; Mahida, YR; Palmer, KR; Patil, DH; Rees, R; Silk, DB; Westaby, D | 1 |
Arroyo, V; Caballería, J; Heredia, D; Ravelli, G; Rodés, J | 1 |
Lanthier, PL; Morgan, MY | 1 |
13 review(s) available for lactitol and Hepatic Encephalopathy
Article | Year |
---|---|
Primary prevention of hepatic encephalopathy post-TIPS: A systematic review and meta-analysis.
Topics: Albumins; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Primary Prevention; Rifaximin | 2023 |
Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System.
Topics: Cathartics; Colonic Neoplasms; Constipation; Diarrhea; Galactosides; Gastrointestinal Diseases; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Inflammatory Bowel Diseases; Lactose; Lactulose; Oligosaccharides; Prebiotics; Probiotics; Sugar Alcohols; Trisaccharides | 2018 |
Disaccharides in the treatment of hepatic encephalopathy.
Topics: Animals; Anti-Infective Agents; Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Sugar Alcohols | 2013 |
[Prevention of hepatic encephalopathy].
Topics: Anti-Bacterial Agents; Central Nervous System Depressants; Contraindications; Diuretics; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Absorption; Lactulose; Liver Cirrhosis; Liver Transplantation; Meta-Analysis as Topic; Peritonitis; Portasystemic Shunt, Surgical; Postoperative Complications; Recurrence; Rifamycins; Rifaximin; Risk Factors; Sugar Alcohols | 2014 |
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic; Sugar Alcohols | 2016 |
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Topics: Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols; Watchful Waiting | 2016 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.
Topics: Anti-Infective Agents; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic; Sugar Alcohols; Treatment Outcome | 2004 |
Nonabsorbable disaccharides for hepatic encephalopathy.
Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols | 2004 |
[Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication].
Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Neomycin; Sugar Alcohols | 2005 |
The treatment of hepatic encephalopathy.
Topics: Amino Acids, Branched-Chain; Anti-Bacterial Agents; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Zinc | 2007 |
Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Treatment Outcome | 1993 |
Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
Topics: Chronic Disease; Clinical Trials as Topic; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Meta-Analysis as Topic; Methods; Research Design; Sugar Alcohols | 1992 |
14 trial(s) available for lactitol and Hepatic Encephalopathy
Article | Year |
---|---|
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
Topics: Acute Disease; Ammonia; Anti-Infective Agents; Double-Blind Method; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Recurrence; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Treatment Outcome | 2003 |
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.
Topics: Adult; Aged; Cathartics; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Complications; Rifamycins; Rifaximin; Sugar Alcohols; Treatment Failure | 2005 |
Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy.
Topics: Aged; Ammonia; Dose-Response Relationship, Drug; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Mental Health; Middle Aged; Psychometrics; Sugar Alcohols; Time Factors; Veins | 1994 |
Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study.
Topics: Aged; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Sugar Alcohols | 1995 |
Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Treatment Outcome | 1993 |
The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.
Topics: Adult; Aged; Feces; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Lipid Metabolism; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols | 1992 |
Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Topics: Adult; Aged; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Sugar Alcohols | 1990 |
Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
Topics: Clinical Trials as Topic; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Psychological Tests; Random Allocation; Sugar Alcohols | 1989 |
Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt.
Topics: Adolescent; Adult; Amino Acids; Clinical Trials as Topic; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Random Allocation; Recurrence; Sugar Alcohols | 1989 |
Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
Topics: Clinical Trials as Topic; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Neuropsychological Tests; Recurrence; Sugar Alcohols | 1988 |
Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Disaccharides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Random Allocation; Sugar Alcohols | 1987 |
Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactose; Male; Middle Aged; Random Allocation; Sugar Alcohols | 1987 |
Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
Topics: Colon; Disaccharides; Fatty Acids, Volatile; Feces; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Neomycin; Sugar Alcohols | 1987 |
Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols | 1987 |
17 other study(ies) available for lactitol and Hepatic Encephalopathy
Article | Year |
---|---|
[Elderly hereditary hemorrhagic telangiectasia female with portosystemic encephalopathy].
Topics: Aged; Amino Acids, Branched-Chain; Diet, Protein-Restricted; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Magnetic Resonance Imaging; Sugar Alcohols; Telangiectasia, Hereditary Hemorrhagic | 2009 |
Prevention of first overt episode of hepatic encephalopathy after TIPS: no easy task.
Topics: Hepatic Encephalopathy; Humans; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Sugar Alcohols | 2006 |
[1st use of lactitol in the treatment of porto-systemic encephalopathy].
Topics: Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Portacaval Shunt, Surgical; Postoperative Complications; Sugar Alcohols | 1982 |
[The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Dogs; Hepatic Encephalopathy; Lactulose; Male; Portacaval Shunt, Surgical; Sugar Alcohols | 1995 |
[Ameliorating effect of lactitol on experimental hepatic encephalopathy in Eck fistula dogs].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dogs; Electroencephalography; Evoked Potentials, Visual; Hepatic Encephalopathy; Male; Portacaval Shunt, Surgical; Sugar Alcohols | 1995 |
[Effects of lactitol on fecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy].
Topics: Aged; Ammonia; Bacteria; Feces; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols | 1995 |
[Lactitol suppresses the disturbance of consciousness caused by experimentally induced hepatic encephalopathy in rats: an EEG study].
Topics: Animals; Consciousness Disorders; Disease Models, Animal; Electroencephalography; Hepatic Encephalopathy; Humans; Lactulose; Rats; Rats, Wistar; Sugar Alcohols | 1995 |
[Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
Topics: Ammonia; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Lactulose; Male; Rats; Rats, Sprague-Dawley; Sugar Alcohols | 1995 |
[Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
Topics: Cholic Acid; Cholic Acids; Colon; Constipation; Gastrointestinal Transit; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Lactulose; Sugar Alcohols | 1993 |
[Lactilol (Importal, 10g in powder made by ZYMA) in the treatment of portal systemic encephalopathy].
Topics: Adult; Aged; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Powders; Sugar Alcohols | 1996 |
[How is bowel function? Satellite symposium at the 19th Congress of the Society of Gastroenterology, 25-26 October 1991].
Topics: Constipation; Gastrointestinal Motility; Hepatic Encephalopathy; Humans; Sugar Alcohols | 1992 |
First and second generation non absorbable disaccharides in the treatment of hepatic encephalopathy.
Topics: Hepatic Encephalopathy; Humans; Lactose; Lactulose; Sugar Alcohols | 1990 |
Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy.
Topics: Animals; Digestion; Feces; Germ-Free Life; Hepatic Encephalopathy; Lactulose; Nitrogen; Proteins; Rats; Rats, Inbred Strains; Sugar Alcohols; Swine; Swine, Miniature | 1990 |
Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?
Topics: Absorption; Disaccharides; Drug Synergism; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Sugar Alcohols | 1990 |
[Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
Topics: Bacteria; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Intestines; Neomycin; Sugar Alcohols | 1989 |
Lactitol.
Topics: Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols | 1987 |
Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
Topics: Adult; Ammonia; Cerebrovascular Circulation; Chronic Disease; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Patient Acceptance of Health Care; Psychological Tests; Sugar Alcohols; Time Factors; Veins | 1985 |